SOAT1 and cancer: In addition, anti-angiogenic factors or immunomodulatory agents have been recorded, as well as some known to inhibit cancer-related signalling, such as PI3K/AKT, Wnt/β-catenin and the JAK/STAT pathway [52,72,76].